Natural history of Type A Niemann-Pick disease: Possible endpoints for therapeutic trials

M. M. McGovern, A. Aron, S. E. Brodie, R. J. Desnick, Melissa P. Wasserstein

Research output: Contribution to journalArticle

71 Citations (Scopus)

Abstract

OBJECTIVE: To describe the disease course and natural history of Type A Niemann-Pick disease (NPD). METHODS: Ten patients with NPD-A (six male, four female; age range at entry: 3 to 6 months) were serially evaluated including clinical neurologic, ophthalmologic, and physical examinations, and assessment of development. Laboratory analyses, abdominal and brain ultrasounds, and chest radiographs also were obtained and information on intercurrent illnesses and cause of mortality was collected. RESULTS: All affected infants had a normal neonatal course and early development. The first symptom detected in all patients was hepatosplenomegaly. Developmental age did not progress beyond 10 months for adaptive behavior, 12 months for expressive language, 9 months for gross motor skills, and 10 months for fine motor skills. Non-neurologic symptoms included frequent vomiting, failure to thrive, respiratory infections, irritability, and sleep disturbance. Neurologic examination at the time of presentation was normal in most patients. Later neurologic examinations revealed progressive hypotonia with loss of the deep tendon reflexes. All patients had cherry red spots by 12 months. The median time from diagnosis to death was 21 months. The cause of death was respiratory failure in nine patients and complications from bleeding in the tenth. CONCLUSIONS: The clinical course in Type A Niemann-Pick disease is similar among affected patients and is characterized by a relentless neurodegenerative course that leads to death, usually within 3 years.

Original languageEnglish (US)
Pages (from-to)228-232
Number of pages5
JournalNeurology
Volume66
Issue number2
DOIs
StatePublished - Jan 2006
Externally publishedYes

Fingerprint

Type A Niemann-Pick Disease
Neurologic Examination
Motor Skills
Therapeutics
Niemann-Pick Diseases
Stretch Reflex
Failure to Thrive
Muscle Hypotonia
Psychological Adaptation
Respiratory Tract Infections
Respiratory Insufficiency
Physical Examination
Vomiting
Cause of Death
Sleep
Language
Thorax
Hemorrhage
Mortality
Brain

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Natural history of Type A Niemann-Pick disease : Possible endpoints for therapeutic trials. / McGovern, M. M.; Aron, A.; Brodie, S. E.; Desnick, R. J.; Wasserstein, Melissa P.

In: Neurology, Vol. 66, No. 2, 01.2006, p. 228-232.

Research output: Contribution to journalArticle

McGovern, M. M. ; Aron, A. ; Brodie, S. E. ; Desnick, R. J. ; Wasserstein, Melissa P. / Natural history of Type A Niemann-Pick disease : Possible endpoints for therapeutic trials. In: Neurology. 2006 ; Vol. 66, No. 2. pp. 228-232.
@article{01c5abb14d8b4cc28dee25841ae4a6b8,
title = "Natural history of Type A Niemann-Pick disease: Possible endpoints for therapeutic trials",
abstract = "OBJECTIVE: To describe the disease course and natural history of Type A Niemann-Pick disease (NPD). METHODS: Ten patients with NPD-A (six male, four female; age range at entry: 3 to 6 months) were serially evaluated including clinical neurologic, ophthalmologic, and physical examinations, and assessment of development. Laboratory analyses, abdominal and brain ultrasounds, and chest radiographs also were obtained and information on intercurrent illnesses and cause of mortality was collected. RESULTS: All affected infants had a normal neonatal course and early development. The first symptom detected in all patients was hepatosplenomegaly. Developmental age did not progress beyond 10 months for adaptive behavior, 12 months for expressive language, 9 months for gross motor skills, and 10 months for fine motor skills. Non-neurologic symptoms included frequent vomiting, failure to thrive, respiratory infections, irritability, and sleep disturbance. Neurologic examination at the time of presentation was normal in most patients. Later neurologic examinations revealed progressive hypotonia with loss of the deep tendon reflexes. All patients had cherry red spots by 12 months. The median time from diagnosis to death was 21 months. The cause of death was respiratory failure in nine patients and complications from bleeding in the tenth. CONCLUSIONS: The clinical course in Type A Niemann-Pick disease is similar among affected patients and is characterized by a relentless neurodegenerative course that leads to death, usually within 3 years.",
author = "McGovern, {M. M.} and A. Aron and Brodie, {S. E.} and Desnick, {R. J.} and Wasserstein, {Melissa P.}",
year = "2006",
month = "1",
doi = "10.1212/01.wnl.0000194208.08904.0c",
language = "English (US)",
volume = "66",
pages = "228--232",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Natural history of Type A Niemann-Pick disease

T2 - Possible endpoints for therapeutic trials

AU - McGovern, M. M.

AU - Aron, A.

AU - Brodie, S. E.

AU - Desnick, R. J.

AU - Wasserstein, Melissa P.

PY - 2006/1

Y1 - 2006/1

N2 - OBJECTIVE: To describe the disease course and natural history of Type A Niemann-Pick disease (NPD). METHODS: Ten patients with NPD-A (six male, four female; age range at entry: 3 to 6 months) were serially evaluated including clinical neurologic, ophthalmologic, and physical examinations, and assessment of development. Laboratory analyses, abdominal and brain ultrasounds, and chest radiographs also were obtained and information on intercurrent illnesses and cause of mortality was collected. RESULTS: All affected infants had a normal neonatal course and early development. The first symptom detected in all patients was hepatosplenomegaly. Developmental age did not progress beyond 10 months for adaptive behavior, 12 months for expressive language, 9 months for gross motor skills, and 10 months for fine motor skills. Non-neurologic symptoms included frequent vomiting, failure to thrive, respiratory infections, irritability, and sleep disturbance. Neurologic examination at the time of presentation was normal in most patients. Later neurologic examinations revealed progressive hypotonia with loss of the deep tendon reflexes. All patients had cherry red spots by 12 months. The median time from diagnosis to death was 21 months. The cause of death was respiratory failure in nine patients and complications from bleeding in the tenth. CONCLUSIONS: The clinical course in Type A Niemann-Pick disease is similar among affected patients and is characterized by a relentless neurodegenerative course that leads to death, usually within 3 years.

AB - OBJECTIVE: To describe the disease course and natural history of Type A Niemann-Pick disease (NPD). METHODS: Ten patients with NPD-A (six male, four female; age range at entry: 3 to 6 months) were serially evaluated including clinical neurologic, ophthalmologic, and physical examinations, and assessment of development. Laboratory analyses, abdominal and brain ultrasounds, and chest radiographs also were obtained and information on intercurrent illnesses and cause of mortality was collected. RESULTS: All affected infants had a normal neonatal course and early development. The first symptom detected in all patients was hepatosplenomegaly. Developmental age did not progress beyond 10 months for adaptive behavior, 12 months for expressive language, 9 months for gross motor skills, and 10 months for fine motor skills. Non-neurologic symptoms included frequent vomiting, failure to thrive, respiratory infections, irritability, and sleep disturbance. Neurologic examination at the time of presentation was normal in most patients. Later neurologic examinations revealed progressive hypotonia with loss of the deep tendon reflexes. All patients had cherry red spots by 12 months. The median time from diagnosis to death was 21 months. The cause of death was respiratory failure in nine patients and complications from bleeding in the tenth. CONCLUSIONS: The clinical course in Type A Niemann-Pick disease is similar among affected patients and is characterized by a relentless neurodegenerative course that leads to death, usually within 3 years.

UR - http://www.scopus.com/inward/record.url?scp=33644921804&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644921804&partnerID=8YFLogxK

U2 - 10.1212/01.wnl.0000194208.08904.0c

DO - 10.1212/01.wnl.0000194208.08904.0c

M3 - Article

C2 - 16434659

AN - SCOPUS:33644921804

VL - 66

SP - 228

EP - 232

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 2

ER -